AU Patent

AU2011323108A1 — Compositions and methods for treating myelofibrosis

Assigned to Impact Biomedicines Inc · Expires 2013-05-09 · 13y expired

What this patent protects

Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-

USPTO Abstract

Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-

Drugs covered by this patent

Patent Metadata

Patent number
AU2011323108A1
Jurisdiction
AU
Classification
—
Expires
2013-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Impact Biomedicines Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.